NervGen Pharma Q3 EPS $(0.04) Beats $(0.12) Estimate
Benzinga Newsdesk 1 day ago
NewsEarningsEarnings Beats
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
NervGen Pharma (NASDAQ:NGEN) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.12) by 66.67 percent.
NervGen Pharma (NASDAQ:NGEN) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.12) by 66.67 percent.
